Published in Cancer Weekly, November 1st, 2005
"Capecitabine and gemcitabine (CapGem) are used in the treatment of a variety of solid tumors including pancreatic and biliary tract carcinomas. The authors evaluated survival, response, and toxicity associated with using a combination of CapGem to treat patients with unresectable or metastatic GBC," scientists in South Korea reported.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.